Literature DB >> 3009545

Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.

R Yarchoan, H G Guo, M Reitz, A Maluish, H Mitsuya, S Broder.   

Abstract

HTLV-I is a transforming human retrovirus that is an etiologic agent of adult T cell leukemia/lymphoma. To investigate the effects of this virus on T cell functions, two OKT3+, OKT4+, OKT8- cytotoxic clones (8.7 and 8.8) specific for allogeneic cells bearing DPw2, a class II histocompatibility antigen, were studied before and after infection with HTLV-I. The clones retained cytotoxic function for up to 70 d after exposure to HTLV-I, even without subsequent antigenic stimulation, but then lost their cytotoxic activity. Prior to infection with HTLV-I, clone 8.8 also lysed OKT3 hybridoma cells; after infection, cytotoxic activity against these OKT3-antibody bearing cells was lost in parallel with the loss of activity against DPw2-bearing target cells. In addition, expression of T3 surface antigen by HTLV-I-infected 8.8 cells was decreased at a time when they lost their cytotoxic activity, possibly contributing to the loss of cytotoxic function. Finally, clone 8.8 could provide help for nonspecific IgG production by autologous B cells when stimulated with irradiated DPw2-bearing non-T cells. After infection with HTLV-I, this helper function became independent of DPw2-stimulation and persisted even when the cytotoxic activity was lost. An OKT4+ T cell clone thus could simultaneously manifest both cytotoxic and helper T cell activities, and these activities were differentially affected after HTLV-I infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009545      PMCID: PMC424547          DOI: 10.1172/JCI112459

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Deregulation of interleukin-2 receptor gene expression in HTLV-I-induced adult T-cell leukemia.

Authors:  M Krönke; W J Leonard; J M Depper; W C Greene
Journal:  Science       Date:  1985-06-07       Impact factor: 47.728

2.  Effect of adult T-cell leukemia cells on pokeweed mitogen-induced normal B-cell differentiation.

Authors:  T Uchiyama; K Sagawa; K Takatsuki; H Uchino
Journal:  Clin Immunol Immunopathol       Date:  1978-05

3.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

4.  T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.

Authors:  G Tosato; I T Magrath; R M Blaese
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

5.  Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma.

Authors:  Y Yamada
Journal:  Blood       Date:  1983-01       Impact factor: 22.113

6.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

7.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia.

Authors:  M Robert-Guroff; Y Nakao; K Notake; Y Ito; A Sliski; R C Gallo
Journal:  Science       Date:  1982-02-19       Impact factor: 47.728

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody.

Authors:  M Robert-Guroff; F W Ruscetti; L E Posner; B J Poiesz; R C Gallo
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

View more
  14 in total

1.  Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission.

Authors:  Nancy Van Prooyen; Heather Gold; Vibeke Andresen; Owen Schwartz; Kathryn Jones; Frank Ruscetti; Stephen Lockett; Prabhakar Gudla; David Venzon; Genoveffa Franchini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-12       Impact factor: 11.205

Review 2.  Viral modulation of T-cell receptor signaling.

Authors:  Keith R Jerome
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

Review 3.  Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.

Authors:  Nancy Van Prooyen; Vibeke Andresen; Heather Gold; Izabela Bialuk; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  Mol Aspects Med       Date:  2010-07-29

4.  Modulation of the cell-mediated immune function by interferon alpha, beta or gamma can partially reverse the immunosuppression induced by human T-cell leukemia virus I in human cord blood cultures.

Authors:  C D'Onofrio; C D Pesce; T Fontana; F Ciprani; E Bonmassar; R Caliŏ
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 5.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

6.  Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.

Authors:  S Matsushita; H Mitsuya; M S Reitz; S Broder
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

7.  Immunological functions and phenotypes of peripheral blood lymphocytes from human T-cell leukemia virus-I carriers.

Authors:  Y Tanaka; S Oda; K Nagata; N Mori; H Sakamoto; S Eto; U Yamashita
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

8.  Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.

Authors:  R Yarchoan; R R Redfield; S Broder
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

9.  Modulation of T-cell responses to a recall antigen in human T-cell leukemia virus type 1-infected individuals.

Authors:  M Suzuki; C S Dezzutti; A Okayama; N Tachibana; H Tsubouchi; N Mueller; R B Lal
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

10.  High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.

Authors:  Peter K C Goon; Tadahiko Igakura; Emmanuel Hanon; Angelina J Mosley; Becca Asquith; Keith G Gould; Graham P Taylor; Jonathan N Weber; Charles R M Bangham
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.